Latest Licensing News

Chariot Resources has secured Nigerian government approval for the transfer of six lithium licenses, marking a key step toward acquiring a majority stake in a promising Nigerian lithium portfolio. This regulatory milestone enables immediate exploration and mining activities at multiple projects amid soaring lithium prices.

Dimerix Limited has completed dosing of the last adult patient in its ACTION3 Phase 3 trial for DMX-200, exceeding its recruitment target and setting the stage for key regulatory milestones.

EVE Health Group has completed R&D on multiple reformulated drug candidates targeting major sexual health and cardiovascular markets, preparing patent filings and licensing strategies to capitalise on a combined $30 billion global opportunity.

South Harz Potash Limited has raised A$1.25 million to fund exploration at its newly licensed copper-gold projects in Sweden, signalling a strategic pivot towards critical minerals and a planned rebrand to Turnstone Resources.

Battery Age Minerals has secured an exclusive evaluation licence with NTUitive to assess advanced germanium technologies, aligning its Austrian and US projects with downstream market specifications and sustainable processing goals.

Critical Resources Limited has successfully demonstrated a solvent-free Dry Supersonic Deposition method to fabricate lithium iron phosphate cathodes, marking a significant step toward scalable, energy-efficient solid-state battery manufacturing.

Peppermint Innovation has attracted a strategic A$2.1 million investment from key Philippine payments companies, accelerating its digital wallet platform’s growth in the country’s fast-evolving market.

Peregrine Gold Limited has announced significant progress across its Pilbara projects, including new sampling programs targeting gold anomalies and approvals for drilling at key prospects. The company’s latest assays and heritage agreements set the stage for upcoming exploration activities.

Reef Casino Trust has issued a second supplementary target’s statement as the takeover bid by Iris Cairns Property Pty Ltd extends to August 2026 due to delayed casino licensing approvals. The board maintains its recommendation for unitholders to accept the offer, pending regulatory outcomes and expert advice.

Bio-Gene Technology Limited reports strong progress in toxicology studies for Flavocide, targeting its first regulatory submission in Australia by March 2027. This milestone sets the stage for global registrations of the novel insecticide with a new mode of action.

Avecho Biotechnology has completed recruitment for the interim analysis cohort of its pivotal Phase III trial for a CBD insomnia treatment, with results expected in June 2026. This milestone could significantly de-risk the program and unlock major market opportunities.

Complii FinTech Solutions reported a $1.35 million loss for H1 FY26 alongside a 6% increase in annual recurring revenue, driven by strategic platform upgrades and expanding client engagement.